Neuroglee gets $2.3 million to develop digital therapies for neurodegenerative illness

by RJ Shara | Dec 3, 2020 | Fundings and Exit, Startups

There are now about 50 million people with dementia internationally, a number the World Health Company expects to triple by 2050. Alzheimer’s is the leading reason for dementia and caretakers are often overwhelmed, without sufficient support. Neuroglee, a Singapore-based health tech start-up, wants to aid with a digital therapeutic platform produced to treat clients in […] Neuroglee’s prescription digital treatment software application for Alzheimer’s, called NG-001, is its primary product. Neuroglee creator and CEO Aniket Singh Rajput told TechCrunch that its first target markets for NG-001 are the United States and Singapore, followed by Japan. …